NASDAQ:IXHL Incannex Healthcare Q1 2027 Earnings Results & Report $1.93 -0.04 (-2.03%) Closing price 11/16/2026 04:00 PM EasternExtended Trading$1.93 0.00 (-0.05%) As of 11/16/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Incannex Healthcare beat analyst earnings expectations in its Q1 2027 results, released November 12, 2026. The company reported EPS of -$0.15 versus the -$0.44 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ1 2027Report DateNovember 12, 2026TimeBefore Market OpensConference Call7:00 AM ET Incannex Healthcare EPS ResultsActual EPS-$0.15Consensus EPS -$0.44Beat/MissBeat by +$0.29One Year Ago EPSN/AEPS Beat Rate3 of last 6 quartersIncannex Healthcare Revenue ResultsActual RevenueN/AExpected Revenue$10 millionBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Incannex Healthcare Q1 2027 Earnings FAQ Did Incannex Healthcare beat earnings estimates for Q1 2027? Incannex Healthcare (NASDAQ:IXHL) reported earnings of -$0.15 per share for Q1 2027, beating the consensus estimate of -$0.44. The report was announced on Thursday, November 12, 2026. Incannex Healthcare Earnings HeadlinesIncannex Healthcare (IXHL) Expected to Release Earnings on FridayNovember 6, 2026 | americanbankingnews.comIncannex Healthcare Inc. (IXHL)November 5, 2026 | finance.yahoo.comYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date. | Paradigm Press (Ad)Incannex Healthcare Inc IXHLNovember 3, 2026 | morningstar.comMIncannex Healthcare Inc. Reports Earnings Results for the Full Year Ended June 30, 2026September 25, 2026 | marketscreener.comMIncannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital PositionSeptember 9, 2026 | globenewswire.comSee More Incannex Healthcare Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Incannex Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Incannex Healthcare and other key companies, straight to your email. Email Address About Incannex HealthcareIncannex Healthcare (NASDAQ:IXHL) is a clinical-stage biopharmaceutical company developing investigational medicines, including cannabinoid-based combination therapies and psychedelic-assisted treatments. Its research focuses on conditions with significant unmet medical needs; its products are in development and are not established as approved treatments. The company’s pipeline has included IHL-42X, a combination of dronabinol and acetazolamide being studied for obstructive sleep apnea, as well as programs targeting inflammatory conditions and traumatic brain injury. Incannex has also pursued research into psychedelic-assisted therapies for mental health conditions. Incannex is an Australian-origin company whose shares trade on Nasdaq under the symbol IXHL. Its work is primarily focused on drug research and development rather than the sale of marketed medicines.View Incannex Healthcare ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/133 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCould Big Buybacks Be the Next Catalyst for These 3 AI Stocks?Cerebras Q3 Results: How Much More Proof Does Wall Street Need? Upcoming Earnings Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.